ASX:LTPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
LTR Pharma Ltd
$0.520
Day Range
$0.515 – $0.525
52 Week Range
$0.335 – $0.810
Volume
76.82K
Avg Volume (10D)
169.35K
Market Cap
$94.52M
Price Chart
Market Statistics
Open$0.520
Previous Close$0.520
Day High$0.525
Day Low$0.515
52 Week High$0.810
52 Week Low$0.335
Valuation
Market Cap94.52M
Shares Outstanding181.78M
Price to Book3.48
Trading Activity
Volume76.82K
Value Traded40.15K
Bid$0.510 × 1,029
Ask$0.520 × 25,429
Performance
1 Day9.57%
5 Day11.96%
13 Week27.16%
52 Week53.73%
YTD-28.47%
Technical Indicators
RSI (14)56.44
50-Day SMA$0.510
200-Day SMA$0.483
Latest News
Biotechnology
LTR Pharma Reports 93% SPONTAN Response in Real-World ED Cohort
LTR Pharma reports 93% real-world ED response to SPONTAN in treatment-experienced men, largest cohort to date, fueling ROXUS US plans.
Biotechnology
LTR Pharma Executes US Commercialisation Agreement with Shed DTC Platform
LTR Pharma inks US ROXUS deal with Shed; targets 150k units in year one via Mavrox telehealth—fast-acting 10-min onset.
Hot Topics
The Weekly Finger: On Green and Gold, and Oil and Gold
Oil inventories near lows despite Iran peace chatter; gold and oil diverge on the energy complex. Small Caps weekly market wrap on ASX stocks.
Biotechnology
LTR Pharma Signs Binding US Telehealth Term Sheet For ROXUS
LTR Pharma signs binding US telehealth term sheet with Shed Holdings for ROXUS via Mavrox; Definitive Agreements in 60 days to kickstart US commercialization.